MPWT
WINT

MassMutual Private Wealth & Trust’s Windtree Therapeutics Inc WINT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20
Closed -$4 – 1000
2017
Q3 		$4 Hold
20
– – ﹤0.01% 1053
2017
Q2 		$7 Hold
20
– – ﹤0.01% 1027
2017
Q1 		$23 Hold
20
– – ﹤0.01% 1002
2016
Q4 		$25 Buy
+20
New +$37 ﹤0.01% 672
2016
Q2 		$39 Hold
20
– – ﹤0.01% 806
2016
Q1 		$33 Hold
20
– – ﹤0.01% 797
2015
Q4 		$61 Hold
20
– – ﹤0.01% 798
2015
Q3 		$523 Hold
20
– – ﹤0.01% 792
2015
Q2 		$506 Hold
20
– – ﹤0.01% 700
2015
Q1 		$338 Buy
+20
New +$394 ﹤0.01% 696
2014
Q4 		– Sell
-20
Closed -$523 – 825
2014
Q3 		$523 Buy
+20
New +$483 ﹤0.01% 755

MassMutual Private Wealth & Trust's WINT Position: Q4 2017 in Review

MassMutual Private Wealth & Trust sold out of Windtree Therapeutics Inc (WINT) in Q4 2017, closing a stake of 20 shares — an estimated $4 sold.

MassMutual Private Wealth & Trust first reported a position in WINT in Q3 2014 and held it in 11 quarters. The position peaked at $523 in Q3 2015. 0 funds tracked by Wall St. Rank hold WINT as of Q4 2017.

  • MassMutual Private Wealth & Trust reported no remaining Windtree Therapeutics Inc position as of Q4 2017 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 20 Windtree Therapeutics Inc shares in Q4 2017, an estimated $4.
  • MassMutual Private Wealth & Trust first reported a position in Windtree Therapeutics Inc in Q3 2014 and held it in 11 quarters.
  • MassMutual Private Wealth & Trust's Windtree Therapeutics Inc position peaked at $523 in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2017.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2017, filed 21 Feb 2018.